You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBI-8000

Showing 1 - 25 of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • HBI-8000 in combination with pembrolizumab
  • Goodyear, Arizona
  • +6 more
Dec 5, 2022

Peripheral T-Cell Lymphoma (PTCL) Trial in Japan, Korea, Republic of (HBI-8000)

Completed
  • Peripheral T-Cell Lymphoma (PTCL)
  • HBI-8000
  • Akita, Japan
  • +22 more
Jun 8, 2022

Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

Active, not recruiting
  • Melanoma
  • +2 more
  • HBI-8000 in combination with nivolumab
  • Phoenix, Arizona
  • +5 more
Jun 11, 2022

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Relapsed or Refractory Peripheral T-cell Lymphoma Trial in Taiwan (Chidamide)

Not yet recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma
  • Kaohsiung, Taiwan
  • +4 more
Apr 17, 2023

Metastatic Colorectal Cancer Trial in New Taipei City (chidamide, celecoxib)

Recruiting
  • Metastatic Colorectal Cancer
  • New Taipei City, Taiwan
    Taipei Medical University Shuang Ho Hospital
Mar 4, 2022

Triple-negative Breast Cancer Trial in Tianjin (Chidamide in combination with chemo)

Unknown status
  • Triple-negative Breast Cancer
  • Chidamide in combination with chemotherapy
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Hospital
Dec 3, 2020

Diffuse Large B-cell Lymphoma Trial in Changchun (Tucidinostat)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Dec 4, 2020

Chronic HIV Trial in Xi'an (Chidamide)

Completed
  • Chronic HIV Infections
  • Xi'an, Shaanxi, China
    Department of Infectious Diseases, Tangdu Hospital, The Fourth M
Jan 12, 2020

Thrombocytopenia Trial in Jinan (Chidamide)

Unknown status
  • Thrombocytopenia
  • Jinan, Shandong, China
    Qilu hospital, Shandong University
Feb 11, 2019

Atrial Fibrillation Trial in Canada, New Zealand, United States (HBI-3000, Placebo)

Recruiting
  • Atrial Fibrillation
  • Birmingham, Alabama
  • +20 more
Jan 23, 2023

Anemia, Sickle Cell Trial in San Diego (HBI-002)

Not yet recruiting
  • Anemia, Sickle Cell
  • San Diego, California
    Contact Company
Nov 17, 2023

MDS Over Time - Comparison of Treated vs Untreated Patients

Completed
  • Myelodysplastic Syndromes
    • Vienna, Austria
      Hanusch Krankenhaus, 3.Medizinische Abteilung
    Nov 21, 2022

    Drug-drug Interaction Trial in West Bend, Melbourne (HBI-3000, Paroxetine)

    Completed
    • Drug-drug Interaction
    • West Bend, Wisconsin
    • +1 more
    Jul 14, 2022

    Health and Wellness Trial in San Francisco (Healthy Beverage Initiative)

    Active, not recruiting
    • Health and Wellness
    • Healthy Beverage Initiative
    • San Francisco, California
      California Pacific Medical Center
    Aug 10, 2022

    Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Puerto Rico, United States (HBI-2376)

    Recruiting
    • Non Small Cell Lung Cancer
    • +6 more
    • Duarte, California
    • +11 more
    Aug 23, 2022

    Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer Trial in Santa Monica, Plantation (HBI-2438)

    Not yet recruiting
    • Lung Cancer
    • +6 more
    • Santa Monica, California
    • +1 more
    Aug 2, 2022

    Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

    Recruiting
    • Sarcoma, Synovial
    • +8 more
    • CYCLOPHOSPHAMIDE and FLUDARABIN
    • +3 more
    • Jerusalem, Israel
      Hadassah Medical Organization
    Mar 15, 2022

    Diffuse Large B Cell Lymphoma Trial in Hangzhou (Chidamide + R-CHOP regimen)

    Unknown status
    • Diffuse Large B Cell Lymphoma
    • Chidamide + R-CHOP regimen
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of Zhejiang University
    Aug 1, 2018

    Leukemia, Acute, MDS Trial in Chengdu (Chidamide, Cyclophosphamide, cyclosporine A)

    Unknown status
    • Leukemia, Acute
    • MDS
    • Chengdu, Sichuan, China
    • +1 more
    Jul 17, 2018

    Physical Inactivity Trial (Community-based intervention, Home-based intervention)

    Completed
    • Physical Inactivity
    • Community-based intervention
    • Home-based intervention
    • (no location specified)
    Sep 12, 2022

    Anemia, Sickle Cell Trial (HBI-002)

    Not yet recruiting
    • Anemia, Sickle Cell
    • (no location specified)
    Dec 1, 2021

    Remote Monitoring of IBD

    Recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • patient reported outcome measures
    • +2 more
    • Den Bosch, Netherlands
    • +4 more
    May 23, 2023

    Local Anesthesia Trial in Damascus (Buffered lidocaine in inferior alveolar nerve block injection, lidocaine 2% in inferior

    Active, not recruiting
    • Local Anesthesia
    • Buffered lidocaine in inferior alveolar nerve block injection
    • lidocaine 2% in inferior alveolar nerve block injection
    • Damascus, Al-Mazzeh Saint, Syrian Arab Republic
      College of dentistry.
    Mar 20, 2023

    IBS - Irritable Bowel Syndrome, Ulcerative Colitis, Crohn Disease Trial in Hamilton (Diet, Gastrointestinal microbiome)

    Recruiting
    • IBS - Irritable Bowel Syndrome
    • +3 more
    • Diet
    • Gastrointestinal microbiome
    • Hamilton, Ontario, Canada
      Hamilton Health Sciences / McMaster University
    Mar 15, 2022